Two successful inpatient courses do not establish the best method for treating zolpidem dependence.
The report describes patients taking very high daily zolpidem doses, reported as 800 and 240 milligrams. Management included clonazepam, trazodone, quetiapine and simplified cognitive behavioral treatment for insomnia. The patients completed detoxification without significant reported withdrawal symptoms.
The cases concern unusual high-dose use, not routine hypnotic treatment. Several interventions occurred together, and there was no comparison regimen. Follow-up support was incomplete. Absence of severe withdrawal in two selected patients cannot establish that the same approach prevents seizures or relapse generally.
For a dependence assessment, distinguish prescribed dose from actual consumption and identify how the dose history was obtained. Document daytime use, dose escalation, symptoms after delayed intake and the full inpatient plan. The benzodiazepine substitution is one part of the observed care, not an independently proven explanation for the reported outcome.
Source reviewed: Two Case Reports of Zolpidem Abuse and a Contemporary Review (PMC13034761). The forensic applications above are interpretive analysis of the supplied paper.
Related reading: Perospirone Added to Clonazepam Addressed Residual Oral Discomfort in Two Cases.